|
go to download area
The Safe Drinking Water and Toxic Enforcement Act of 1986 (Proposition
65) requires the Governor to publish, and update at least annually,
a list of chemicals known to the State to cause cancer or reproductive
toxicity. The Office of Environmental Health Hazard Assessment (OEHHA)
is the lead agency for the implementation of Proposition 65.
On September 29, 2000, OEHHA published
a notice in the California Regulatory Notice Register (Register
2000, No. 39-Z) soliciting information which may be relevant to
the evaluation of certain chemicals under consideration for possible
administrative listing within the context of the Proposition 65
administrative listing regulatory criteria in Title 22 of the California
Code of Regulations (22 CCR) Section
12306.
A public forum was held on October 26, 2000 in Oakland, California
to provide an opportunity for interested parties to present oral
comments and to discuss the scientific data and other information
relevant to a determination whether these chemicals meet the criteria
for listing set forth in 22 CCR Section 12306. OEHHA has received
requests to extend the comment period for famciclovir, atorvastatin
calcium, fluvastatin sodium and nimodipine to allow for the submittal
of complete and relevant scientific information. OEHHA hereby extends
the public comment period to Friday, December 8, 2000 for famciclovir
and to Thursday, December 28, 2000 for atorvastatin calcium, fluvastatin
sodium, and nimodipine.
Written comments, along with supporting information, may be submitted
in triplicate to: (Please note our new address effective December
1, 2000)
Cynthia Oshita
Office of Environmental Health Hazard Assessment
Street address: 1001 I Street
Sacramento, California 95814
Mailing address: P.O. Box 4010
Sacramento, California 95812-4010
FAX: (916) 327-1097 Telephone: (916) 445-6900
In order to be considered, comments on famciclovir must be postmarked
(if sent by mail) or received at OEHHA (if hand-delivered or sent
by fax) by 5 p.m., December 8, 2000 and comments on atorvastatin
calcium, fluvastatin sodium and nimodipine must be postmarked (if
sent by mail) or received at OEHHA (if hand-delivered or sent by
fax) by 5 p.m., December 28, 2000.
Download
a copy of this notice as a PDF file.
You will need the free program Adobe Acrobat Reader to view or
print PDF files 
For questions regarding Proposition 65, please contact the Cynthia
Oshita in the Proposition 65 Implementation Program
For help with this web site please contact the Web
Mistress
|
